TI
GCVRZ

Truehand Inc’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Truehand Inc’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-116
Closed – – 186
2019
Q4 		$0 Hold
116
– – ﹤0.01% 189
2019
Q3 		$0 Hold
116
– – ﹤0.01% 189
2019
Q2 		$0 Hold
116
– – ﹤0.01% 199
2019
Q1 		$0 Hold
116
– – ﹤0.01% 204
2018
Q4 		$0 Buy
+116
New +$58 ﹤0.01% 203

Truehand Inc's GCVRZ Position: Q1 2020 in Review

Truehand Inc sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 116 shares.

Truehand Inc first reported a position in GCVRZ in Q4 2018 and held it in 5 quarters. The position peaked at $0 in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

  • Truehand Inc reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • Truehand Inc sold 116 Sanofi Contingent Value Rights shares in Q1 2020.
  • Truehand Inc first reported a position in Sanofi Contingent Value Rights in Q4 2018 and held it in 5 quarters.
  • Truehand Inc's Sanofi Contingent Value Rights position peaked at $0 in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Truehand Inc's 13F filing for Q1 2020, filed 7 Apr 2020.